SCHEMBL17781787

SCHEMBL17781787

Cn1ncc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)cc3[N+](=O)[O-])c(Oc3ccc4[nH]ccc4c3)c2)CC1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 4/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1955102 0.91 BCL2 (0.81) BCL2
SCHEMBL19424700 0.87 BCL2 (0.71) BCL2
SCHEMBL1955105 0.86 BCL2 (0.65) BCL2
SCHEMBL1810749 0.80 BCL2 (1.00) BCL2
SCHEMBL30467960 0.80 BCL2 (1.00) BCL2
SCHEMBL2505947 0.80 BCL2 (0.85) BCL2
SCHEMBL19419663 0.79 BCL2 (0.78) BCL2
SCHEMBL1956220 0.79 BCL2 (0.82) BCL2
SCHEMBL1955004 0.79 BCL2 (0.80) BCL2
SCHEMBL1957132 0.78 BCL2 (0.84) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376480-B1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES ABBVIE INC (US) 2016-06-01 — — EP disclosed
Send feedback